September 26, 2021
  • September 26, 2021

Eye diseases

Ways to keep your heart healthy

by on September 25, 2021 0

‘Use the heart to connect‘- this year’s theme which sums up the values ​​of World Heart Day this year. The World Heart Federation holds World Heart Day on September 29 of each year to highlight the importance of being active and staying informed about cardiovascular health and disease. Around the world, World Heart Day...

Read More

DL Eyewear Review 2021: Frames and Philanthropy

by on September 24, 2021 0

If you are shopping for glasses, you are in good company. The Vision Council estimates that around 164 million American adults wear eyeglasses. There are many retailers to meet the needs of this vast customer base, including online stores and physical stores. DL Eyewear, founded by actor Dan Levy, has an interesting hybrid model....

Read More

Acceleration programs make Riverside the mecca for growing startups

by on September 24, 2021 0

Posted: 23/09/2021 Drs. Shailendra Sing and Eamonn Keogh, co-founders of FarmSense and Core Technology. Courtesy of FarmSense. FarmSense, founded in 2016 by engineering faculty members at UC Riverside (UCR), designed an award-winning system to replace sticky traps with artificial intelligence and analytics to improve insect monitoring and crop management. The startup is preparing to...

Read More

Viridian Therapeutics Announcement – GuruFocus.com

by on September 23, 2021 0

WALTHAM, Mass., September 23, 2021 (GLOBE NEWSWIRE) – Viridian Therapeutics, Inc. (VRDN), a biopharmaceutical company providing new treatments for patients with serious illnesses but underserved by today’s therapies, announced today the closing of a public offering of 7,344,543 common shares, which includes the full exercise by the underwriters of their option to purchase up...

Read More

AstraZeneca Invests in Imperial’s Self-Amplifying RNA Technology with Eye on Future Drugs

by on September 23, 2021 0

LONDON (Reuters) – AstraZeneca Plc on Thursday reached an agreement with the company behind the experimental COVID-19 vaccine at Imperial College London to develop and sell drugs based on its self-RNA technology platform. amplifying in other pathological areas. FILE PHOTO: The AstraZeneca logo is seen outside its North American headquarters in Wilmington, Delaware, USA,...

Read More

Novartis acquires Arctos Medical, thereby expanding its optogenetics profile

by on September 22, 2021 0

The acquisition of Arctos Medical by Novartis could lead to significant advances in optogenetic therapies for patients with vision loss. Novartis announced the acquisition of Arctos Medical on September 21, 2021, giving it access to Arctos’ preclinical adeno-associated viral vector gene therapy program and its proprietary technology for its ophthalmology portfolio. Novartis hopes to...

Read More

Experts Consider More Hawaii Travel Tests To Contain COVID

by on September 22, 2021 0

HONOLULU – Authorities in Hawaii are under pressure to increase COVID-19 testing for travelers as the islands face a record spate of new infections, hospitalizations and deaths. The calls come as federal guidelines change to require negative viral tests of vaccinated and unvaccinated people coming to the United States Despite evidence that more COVID-19...

Read More

Kala Pharmaceuticals Reports Incentive Grant Under NASDAQ Listing Rule 5635 (c) (4) | Your money

by on September 21, 2021 0

WATERTOWN, Mass., September 21, 2021 (GLOBE NEWSWIRE) – Kala Pharmaceuticals, Inc. (NASDAQ: KALA), today announced that the Company has granted non-statutory stock options to new employees as than incentive benefits outside of the Company’s 2017 Stock Incentive. Plan in accordance with NASDAQ Listing Rule 5635 (c) (4). The Company has granted stock options to...

Read More

PYC Therapeutics announces upcoming poster presentations highlighting preclinical data from its ocular and neurological development programs at TIDES USA and OTS 2021

by on September 21, 2021 0

SAN DIEGO and PERTH, Australia, September 21, 2021 / PRNewswire / – PYC Therapeutics (ASX: PYC), a biotechnology company combining two complementary platform technologies (selective drug delivery and precision drug design) to develop a new generation of life-changing RNA therapies patients with inherited diseases, today announced two upcoming virtual poster presentations highlighting preclinical data...

Read More